Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Gheddar

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Drug Testing and Analysis|September 17, 2024
Interest of Hair Tests to Discriminate a Tail End of a Voluntary Doping Regimen From the Use of a Contaminated Medicine in Case of Challenging an Antidoping Rule Violation. VI. Case Example With TrimetazidinePascal Kintz, Laurie Gheddar
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 29, 2025
Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagoguePascal Kintz, Laurie Gheddar
Drug Testing and Analysis|March 14, 2024
Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti-doping rule violation. IV. Case example with mesterolonePascal Kintz, Laurie Gheddar
Clinical Chemistry and Laboratory Medicine|April 28, 2026
Identification of prohibited substances in contaminated dietary supplements associated with adverse analytical findings in athletesPascal Kintz, Laurie Gheddar
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 26, 2024
Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authoritiesPascal Kintz, Laurie Gheddar
Drug Testing and Analysis|February 15, 2024
Interest of hair tests to discriminate a tail end of a doping regimen from a meat contamination in case of challenging an antidoping rule violation. III. Case report involving boldenonePascal Kintz, Laurie Gheddar
Journal of Analytical Toxicology|May 8, 2025
Drug transfer during intimate moments can produce an adverse analytical finding during a doping control. Case report with ligandrolPascal Kintz, Laurie Gheddar
Drug Testing and Analysis|December 21, 2023
Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti-doping rule violation? II. Case report involving chlortalidonePascal Kintz, Laurie Gheddar
Drug Testing and Analysis|August 1, 2024
Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti-doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been establishedPascal Kintz, Alice Ameline, Laurie Gheddar
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 18, 2024
Evidence of ostarine excretion in oral fluid after a single controlled oral administrationPascal Kintz, Laurie Gheddar, Delphine Garnier
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Drug Testing and Analysis|September 17, 2024
Interest of Hair Tests to Discriminate a Tail End of a Voluntary Doping Regimen From the Use of a Contaminated Medicine in Case of Challenging an Antidoping Rule Violation. VI. Case Example With TrimetazidinePascal Kintz, Laurie Gheddar
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 29, 2025
Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagoguePascal Kintz, Laurie Gheddar
Drug Testing and Analysis|March 14, 2024
Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti-doping rule violation. IV. Case example with mesterolonePascal Kintz, Laurie Gheddar
Clinical Chemistry and Laboratory Medicine|April 28, 2026
Identification of prohibited substances in contaminated dietary supplements associated with adverse analytical findings in athletesPascal Kintz, Laurie Gheddar
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 26, 2024
Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authoritiesPascal Kintz, Laurie Gheddar
Drug Testing and Analysis|February 15, 2024
Interest of hair tests to discriminate a tail end of a doping regimen from a meat contamination in case of challenging an antidoping rule violation. III. Case report involving boldenonePascal Kintz, Laurie Gheddar
Journal of Analytical Toxicology|May 8, 2025
Drug transfer during intimate moments can produce an adverse analytical finding during a doping control. Case report with ligandrolPascal Kintz, Laurie Gheddar
Drug Testing and Analysis|December 21, 2023
Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti-doping rule violation? II. Case report involving chlortalidonePascal Kintz, Laurie Gheddar
Drug Testing and Analysis|August 1, 2024
Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti-doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been establishedPascal Kintz, Alice Ameline, Laurie Gheddar
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 18, 2024
Evidence of ostarine excretion in oral fluid after a single controlled oral administrationPascal Kintz, Laurie Gheddar, Delphine Garnier
Pageof 7